In patients undergoing atrial fibrillation ablation, higher levels of galectin-3 and larger left atrial diameters, which reflect more extensive left atrial remodeling, independently predict recurrences of arrhythmia, whether the AF is paroxysmal or persistent, and identify patients at low, intermediate, and high risk. This evidence concerns the gene LGALS3 and atrial fibrillation.